Insider Trading activities at Insys Therapeutics, Inc. (INSY)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Insys Therapeutics, Inc. (INSY) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Insys Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1516479.

Total stock buying since 2014: $3,711,044.
Total stock sales since 2014: $18,785,560.
Total stock option exercises since 2014: $2,593,733.


12 insiders reported insider trading activities at Insys Therapeutics, Inc. (INSY):
Insider trading activities of Tambi Brian
Insider trading activities of John N Kapoor Trust Dated September 20 1989
Insider trading activities of Fourteau Patrick
Insider trading activities of Brennan Daniel
Insider trading activities of Motahari Saeed
Insider trading activities of Baker Darryl S
Insider trading activities of Vishnoi Rohit
Insider trading activities of Kapoor John N
Insider trading activities of Meyer Steven J
Insider trading activities of Babich Michael L
Insider trading activities of Stanley Theodore H
Insider trading activities of Del Fosse Franc

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Insys Therapeutics, Inc. (INSY).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2018 0 $0 166,504 $1,067,290 162,504 $317,370
2017 44,900 $473,543 0 $0 20,000 $52,500
2016 65,700 $855,184 51,781 $918,272 75,083 $598,227
2015 25,000 $670,425 227,159 $11,907,861 208,068 $1,030,369
2014 69,500 $1,711,892 125,000 $4,892,137 150,991 $595,267

Table 2. Monthly summary of insider trading at Insys Therapeutics, Inc. (INSY).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-05 0 $0 166,504 $1,067,290 162,504 $317,370
2017-08 23,000 $205,399 0 $0 10,000 $16,200
2017-06 9,400 $116,532 0 $0 0 $0
2017-05 12,500 $151,612 0 $0 10,000 $36,300
2016-11 10,000 $107,490 0 $0 0 $0
2016-09 0 $0 0 $0 500 $6,785
2016-08 5,700 $105,854 35,781 $657,952 16,194 $106,121
2016-07 0 $0 0 $0 695 $10,035
2016-06 0 $0 16,000 $260,320 17,194 $74,801
2016-05 50,000 $641,840 0 $0 10,500 $142,485
2016-04 0 $0 0 $0 12,000 $103,200
2016-02 0 $0 0 $0 18,000 $154,800
2015-11 25,000 $670,425 30,000 $794,400 0 $0
2015-09 0 $0 4,000 $148,170 20,068 $40,550
2015-06 0 $0 15,000 $659,799 10,000 $132,700
2015-05 0 $0 53,159 $3,122,580 28,000 $70,700
2015-03 0 $0 95,000 $5,615,948 120,000 $620,678
2015-02 0 $0 30,000 $1,566,964 30,000 $165,741
2014-12 0 $0 0 $0 2,500 $8,125
2014-11 0 $0 105,000 $4,088,737 80,000 $188,800
2014-10 0 $0 20,000 $803,400 35,000 $119,550
2014-08 3,000 $101,910 0 $0 0 $0
2014-06 50,000 $1,244,875 0 $0 0 $0
2014-05 16,500 $365,107 0 $0 33,491 $278,792

Table 3. Detailed insider trading at Insys Therapeutics, Inc. (INSY)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-05-10 Tambi Brian (Director) Sale 166,504 6.41 1,067,290
2018-05-10 Tambi Brian (Director) Option Ex 162,504 1.95 317,370
2017-08-11 Kapoor John N (Director) Buy 17,500 8.93 156,345
2017-08-10 Motahari Saeed (President & CEO) Buy 5,500 8.92 49,054
2017-08-04 Fourteau Patrick (Director) Option Ex 10,000 1.62 16,200
2017-06-14 Motahari Saeed (President & CEO) Buy 5,400 11.10 59,956
2017-06-01 Vishnoi Rohit (Director) Buy 4,000 14.14 56,576
2017-05-26 Fourteau Patrick (Director) Option Ex 10,000 3.63 36,300
2017-05-18 Meyer Steven J (Director) Buy 8,000 12.21 97,680
2017-05-16 Motahari Saeed (President & CEO) Buy 4,500 11.98 53,932
2016-11-04 Meyer Steven J (Director) Buy 10,000 10.75 107,490
2016-09-01 Meyer Steven J (Director) Option Ex 500 13.57 6,785
2016-08-16 Stanley Theodore H (Director) Sale 15,000 18.02 270,300
2016-08-16 Stanley Theodore H (Director) Option Ex 15,000 5.96 89,400
2016-08-12 Kapoor John N (President & CEO) Buy 5,700 18.57 105,854
2016-08-11 Fourteau Patrick (Director) Sale 15,000 18.46 276,900
2016-08-09 Brennan Daniel (Exec VP & Chf Operations Off.) Sale 5,781 19.16 110,752
2016-08-04 Meyer Steven J (Director) Option Ex 1,194 14.01 16,721
2016-07-06 Meyer Steven J (Director) Option Ex 695 14.44 10,035
2016-06-07 Meyer Steven J (Director) Option Ex 1,194 14.01 16,721
2016-06-06 Stanley Theodore H (Director) Sale 16,000 16.27 260,320
2016-06-06 Stanley Theodore H (Director) Option Ex 16,000 3.63 58,080
2016-05-23 Baker Darryl S (Chief Financial Officer) Option Ex 10,000 13.57 135,700
2016-05-18 Meyer Steven J (Director) Option Ex 500 13.57 6,785
2016-05-12 Kapoor John N (President & CEO) Buy 10,000 12.41 124,120
2016-05-11 Kapoor John N (President & CEO) Buy 40,000 12.94 517,720
2016-04-14 Meyer Steven J (Director) Option Ex 12,000 8.60 103,200
2016-02-05 Meyer Steven J (Director) Option Ex 18,000 8.60 154,800
2015-11-17 Kapoor John N (President & CEO) Buy 5,000 29.77 148,875
2015-11-12 Fourteau Patrick (Director) Sale 30,000 26.48 794,400
2015-11-12 Kapoor John N (President & CEO) Buy 10,000 26.35 263,500
2015-11-11 Kapoor John N (President & CEO) Buy 10,000 25.80 258,050
2015-09-22 Babich Michael L (President and CEO) Option Ex 16,068 1.62 26,030
2015-09-14 Stanley Theodore H (Director) Sale 2,000 38.08 76,160
2015-09-14 Stanley Theodore H (Director) Option Ex 2,000 3.63 7,260
2015-09-10 Stanley Theodore H (Director) Sale 2,000 36.01 72,010
2015-09-10 Stanley Theodore H (Director) Option Ex 2,000 3.63 7,260
2015-06-10 Del Fosse Franc (General Counsel) Sale 10,000 34.48 344,799
2015-06-10 Del Fosse Franc (General Counsel) Option Ex 10,000 13.27 132,700
2015-06-05 Meyer Steven J (Director) Sale 5,000 63.00 315,000
2015-05-27 Tambi Brian (Director) Sale 3,100 60.09 186,279
2015-05-27 Tambi Brian (Director) Option Ex 3,100 1.22 3,782
2015-05-27 Fourteau Patrick (Director) Sale 1,311 60.14 78,843
2015-05-26 Tambi Brian (Director) Sale 1,800 60.00 108,000
2015-05-26 Tambi Brian (Director) Option Ex 1,800 1.22 2,196
2015-05-26 Fourteau Patrick (Director) Sale 4,784 60.00 287,040
2015-05-20 Tambi Brian (Director) Sale 3,900 60.14 234,546
2015-05-20 Tambi Brian (Director) Option Ex 3,900 1.22 4,758
2015-05-20 Fourteau Patrick (Director) Sale 6,095 60.00 365,700
2015-05-19 Tambi Brian (Director) Sale 1,200 60.01 72,012
2015-05-19 Tambi Brian (Director) Option Ex 1,200 1.22 1,464
2015-05-19 Fourteau Patrick (Director) Sale 2,969 60.00 178,140
2015-05-18 Baker Darryl S (Chief Financial Officer) Sale 10,000 59.12 591,150
2015-05-11 Meyer Steven J (Director) Sale 18,000 56.72 1,020,870
2015-05-11 Meyer Steven J (Director) Option Ex 18,000 3.25 58,500
2015-03-20 Babich Michael L (President and CEO) Option Ex 5,000 3.25 16,250
2015-03-17 Babich Michael L (President and CEO) Sale 27,400 58.09 1,591,748
2015-03-17 Babich Michael L (President and CEO) Option Ex 27,400 7.26 198,924
2015-03-16 Babich Michael L (President and CEO) Sale 47,600 59.33 2,824,012
2015-03-16 Babich Michael L (President and CEO) Option Ex 77,600 4.29 332,904
2015-03-11 Fourteau Patrick (Director) Sale 10,000 59.94 599,360
2015-03-10 Stanley Theodore H (Director) Sale 3,300 60.03 198,085
2015-03-10 Stanley Theodore H (Director) Option Ex 3,300 7.26 23,958
2015-03-05 Stanley Theodore H (Director) Sale 6,700 60.11 402,743
2015-03-05 Stanley Theodore H (Director) Option Ex 6,700 7.26 48,642
2015-02-09 Baker Darryl S (Chief Financial Officer) Sale 8,752 52.18 456,714
2015-02-09 Baker Darryl S (Chief Financial Officer) Option Ex 8,752 7.26 63,539
2015-02-06 Baker Darryl S (Chief Financial Officer) Sale 21,248 52.25 1,110,250
2015-02-06 Baker Darryl S (Chief Financial Officer) Option Ex 21,248 4.81 102,202
2014-12-19 Babich Michael L (President and CEO) Option Ex 2,500 3.25 8,125
2014-11-19 Fourteau Patrick (Director) Sale 25,000 39.11 977,675
2014-11-04 Babich Michael L (President and CEO) Sale 7,500 37.27 279,502
2014-11-04 Babich Michael L (President and CEO) Option Ex 7,500 2.36 17,700
2014-11-03 Babich Michael L (President and CEO) Sale 72,500 39.06 2,831,560
2014-11-03 Babich Michael L (President and CEO) Option Ex 72,500 2.36 171,100
2014-10-21 Babich Michael L (President and CEO) Sale 20,000 40.17 803,400
2014-10-21 Babich Michael L (President and CEO) Option Ex 20,000 3.54 70,800
2014-10-16 Babich Michael L (President and CEO) Option Ex 5,000 3.25 16,250
2014-10-10 Babich Michael L (President & CEO) Option Ex 10,000 3.25 32,500
2014-08-13 Stanley Theodore H (Director) Buy 3,000 33.97 101,910
2014-06-16 John N Kapoor Trust Dated September 20 1989 (10% Owner) Buy 5,000 26.19 130,965
2014-06-13 John N Kapoor Trust Dated September 20 1989 (10% Owner) Buy 5,000 25.27 126,350
2014-06-12 John N Kapoor Trust Dated September 20 1989 (10% Owner) Buy 20,000 24.84 496,760
2014-06-11 John N Kapoor Trust Dated September 20 1989 (10% Owner) Buy 20,000 24.54 490,800
2014-05-19 Kapoor John N (Director) Option Ex 15,991 11.37 181,817
2014-05-19 Stanley Theodore H (Director) Buy 1,000 24.83 24,830
2014-05-15 Babich Michael L (President and CEO) Option Ex 7,500 3.25 24,375
2014-05-15 Fourteau Patrick (Director) Buy 7,500 22.73 170,437
2014-05-15 Meyer Steven J (Director) Buy 5,000 21.38 106,900
2014-05-15 Baker Darryl S (Chief Financial Officer) Option Ex 10,000 7.26 72,600
2014-05-15 Stanley Theodore H (Director) Buy 3,000 20.98 62,940

Insider trading activities including stock purchases, stock sales, and option exercises of INSY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Insys Therapeutics, Inc. (symbol INSY, CIK number 1516479) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.